Tempest Therapeutics, Inc. TPST 深 沪
等待开盘 02-06 09:30:00 美东时间
2.23
-0.150
-6.30%
华盛通- 最 高2.40
- 今 开2.19
- 成交量 15.77万股
- 最 低 2.17
- 昨 收 2.38
- 总市值 785.03万
- 52周最高 12.3682
- 市盈率 静 --
- 换手率 4.48%
- 52周最低 2.17
- 委 比 -45.99%
- 总股本 352.03万
- 历史最高 3381.30
- 量 比 0.50
- 振 幅 9.66%
- 历史最低 2.17
- 每 手 1
- 风险率 2.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers IO Biotech (NASDAQ:IOBT) stock increased by 76.7% to $0.37 during Thur...
01-23 01:05
HC Wainwright & Co. Upgrades Tempest Therapeutics to Buy, Announces $11 Price Target
HC Wainwright & Co. analyst Joseph Pantginis upgrades Tempest Therapeutics (NASDAQ:TPST) from Neutral to Buy and announces $11 price target.
01-22 19:48
Tempest Therapeutics Announces ~$4.25M Offering Of 1.2M Common Stock, 1.2M Warrants At $3.625/Share
Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has entered into a
2025-11-25 21:03
Why Tempest Therapeutics (TPST) Stock Is Down 45% Today
Tempest Therapeutics shares fell Wednesday after the announcement of an all-stock acquisition of dual-CAR T programs from Factor Bioscience.
2025-11-20 00:33
Tempest Therapeutics Signs Agreements To Acquire Certain Dual-Targeting Chimeric Antigen Receptor-T Programs From Factor Bioscience
Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest" or "the Company"), a clinical-stage biotechnology company with a pipeline of targeted and immune-mediated therapeutics to fight cancer, today announced that it has
2025-11-19 22:04
Tempest Therapeutics Q3 EPS $(0.79) Beats $(3.27) Estimate
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(3.27) by 75.84 percent. This is a 85.15 percent increase over losses of $(5.32) per share
2025-11-05 21:34
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares rose 52.4% to $1.0 during Thursday's af...
2025-09-05 05:13
Tempest Therapeutics Q2 EPS $(2.07) Beats $(3.23) Estimate
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(2.07) per share which beat the analyst consensus estimate of $(3.23) by 35.91 percent. This is a 62.5 percent increase over losses of $(5.52) per share
2025-08-12 04:22
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update
Received clearance to proceed with pivotal trial of amezalpat combination thera...
2025-08-12 04:12
